6-Month Buy/Sell Trend
Buys
Sells
▶
2026-04-20
▼ 1 sell
· $213K
4 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Craig Kevin James | Chief Medical Officer | M | 27,280 | $2 | $41K | Plan | Apr 22 |
| Craig Kevin James | Chief Medical Officer | M | 15,299 | $2 | $28K | Plan | Apr 22 |
| Craig Kevin James | Chief Medical Officer | ▼ Sell | 42,579 | $5 | $213K | Plan | Apr 22 |
| Craig Kevin James | Chief Medical Officer | M | 27,280 | $0 | $0 | Plan | Apr 22 |
| Craig Kevin James | Chief Medical Officer | M | 15,299 | $0 | $0 | Plan | Apr 22 |
▶
2026-04-08
6 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Angermayer Christian | — | M | 46,070 | $2 | $87K | Apr 10 | |
| Angermayer Christian | — | M | 410,162 | $2 | $673K | Apr 10 | |
| Angermayer Christian | — | M | 103,000 | $1 | $138K | Apr 10 | |
| Angermayer Christian | — | M | 46,070 | $0 | $0 | Apr 10 | |
| Angermayer Christian | — | M | 410,162 | $0 | $0 | Apr 10 | |
| Angermayer Christian | — | M | 103,000 | $0 | $0 | Apr 10 |
▶
2026-03-20
▼ 1 sell
· $355K
4 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Craig Kevin James | Chief Medical Officer | M | 76,224 | $1 | $90K | Plan | Mar 24 |
| Craig Kevin James | Chief Medical Officer | M | 23,776 | $2 | $36K | Plan | Mar 24 |
| Craig Kevin James | Chief Medical Officer | ▼ Sell | 100,000 | $4 | $355K | Plan | Mar 24 |
| Craig Kevin James | Chief Medical Officer | M | 76,224 | $0 | $0 | Plan | Mar 24 |
| Craig Kevin James | Chief Medical Officer | M | 23,776 | $0 | $0 | Plan | Mar 24 |
▶
2026-01-30
12 other
⚡ 6 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Craig Kevin James | Chief Medical Officer | A | 675,000 | $0 | $0 | Feb 3 | |
| Craig Kevin James | Chief Medical Officer | A | 150,000 | $0 | $0 | Feb 3 | |
| Short Glenn Frank | Chief Scientific Officer | A | 675,000 | $0 | $0 | Feb 3 | |
| Short Glenn Frank | Chief Scientific Officer | A | 150,000 | $0 | $0 | Feb 3 | |
| Rao Srinivas | See remarks | A | 1,988,000 | $0 | $0 | Feb 3 | |
| Rao Srinivas | See remarks | A | 442,000 | $0 | $0 | Feb 3 | |
| Kochendoerfer Gerd | Chief Operating Officer | A | 675,000 | $0 | $0 | Feb 3 | |
| Kochendoerfer Gerd | Chief Operating Officer | A | 150,000 | $0 | $0 | Feb 3 | |
| Johnson Anne Nagengast | Chief Financial Officer | A | 525,000 | $0 | $0 | Feb 3 | |
| Johnson Anne Nagengast | Chief Financial Officer | A | 117,000 | $0 | $0 | Feb 3 | |
| Barrett Christopher Ryan Cave | See remarks | A | 675,000 | $0 | $0 | Feb 3 | |
| Barrett Christopher Ryan Cave | See remarks | A | 150,000 | $0 | $0 | Feb 3 |
▶
2026-01-02
▼ 1 sell
· $154K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Feilding-Mellen Cosmo | — | ▼ Sell | 39,594 | $4 | $154K | Jan 6 |
▶
2025-11-25
2 other
▶
2025-11-04
1 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Braunstein Scott | — | A | 56,818 | $0 | $0 | Nov 6 |
▶
2025-11-05
7 other
⚡ 2 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Feilding-Mellen Cosmo | — | A | 7,702,990 | — | — | Nov 6 | |
| Feilding-Mellen Cosmo | — | A | 103,000 | $0 | $0 | Nov 6 | |
| Feilding-Mellen Cosmo | — | A | 40,400 | $0 | $0 | Nov 6 | |
| HERSHBERG ROBERT | — | A | 456,011 | $0 | $0 | Nov 6 | |
| HERSHBERG ROBERT | — | A | 97,716 | $0 | $0 | Nov 6 | |
| HERSHBERG ROBERT | — | A | 62,394 | $0 | $0 | Nov 6 | |
| HERSHBERG ROBERT | — | A | 103,000 | $0 | $0 | Nov 6 |